Last update 08 May 2025
Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd.

Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd.

Private Company|1999|Heilongjiang Sheng, China

Overview

Tags

Immune System Diseases
Congenital Disorders
Endocrinology and Metabolic Disease
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases2
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
PP2A(Protein phosphatase 2A)1
OAT1(solute carrier family 22 member 6)1

Related

2
Drugs associated with Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd.
Mesalamine
Target
PP2A
Mechanism
PP2A inhibitors
Active Org.
AbbVie, Inc.AbbVie, Inc. [+12]
Originator Org.
SanofiSanofi
Active Indication
Ulcerative colitis, active moderate [+7]
Inactive Indication
Colitis, Collagenous [+9]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Switzerland
First Approval Date01 Jan 1984
Probenecid
Target
OAT1
Mechanism
OAT1 inhibitors
Active Org.
TrippBio, Inc.TrippBio, Inc. [+2]
Originator Org.
Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp.
Active Indication
Gout [+4]
Inactive Indication
Hyperuricemia
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date26 Apr 1951
1
Clinical Trials associated with Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd.
CTR20250742
/ Not yet recruitingNot Applicable
美沙拉秦肠溶片生物等效性试验
[Translation] Bioequivalence study of mesalazine enteric-coated tablets
100 Clinical Results associated with Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Sunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 13 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Mesalamine
 ( PP2A )		Colitis, Ulcerative
More
Approved
Probenecid
 ( OAT1 )		Gout
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free